NSPR - InspireMD, Inc.


1.64
-0.010   -0.610%

Share volume: 26,293
Last Updated: 03-10-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$1.65
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
35%
Profitability 25%
Dept financing 17%
Liquidity 51%
Performance 45%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
-4.93%
3 Months
-15.90%
6 Months
-32.23%
1 Year
-41.22%
2 Year
-35.80%
Key data
Stock price
$1.64
P/E Ratio 
0.00
DAY RANGE
$1.61 - $1.65
EPS 
-$0.82
52 WEEK RANGE
$1.51 - $2.99
52 WEEK CHANGE
-$41.64
MARKET CAP 
100.547 M
YIELD 
N/A
SHARES OUTSTANDING 
42.371 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
-0.43
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$44,232
AVERAGE 30 VOLUME 
$26,428
Company detail
CEO: Marvin L. Slosman
Region: US
Website: inspiremd.com
Employees: 50
IPO year: 2011
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

InspireMD, Inc. focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company sells its products through local distributors.

Recent news